
P008: Impact of bone marrow involvement on early PET response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma
Author(s) -
Voltin ConradAmadeus,
Kreissl Stefanie,
Kaul Helen,
Bühnen Ina,
Mettler Jasmin,
Pabst Thomas,
Eichenauer Dennis A.,
Fuchs Michael,
Diehl Volker,
Dietlein Markus,
Engert Andreas,
Borchmann Peter,
Kobe Carsten
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000890600.53871.dd
Subject(s) - medicine , procarbazine , hazard ratio , vincristine , etoposide , lymphoma , progression free survival , positron emission tomography , cyclophosphamide , bone marrow , oncology , stage (stratigraphy) , hodgkin's lymphoma , nuclear medicine , chemotherapy , confidence interval , paleontology , biology